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ABSTRACT. Objective. To quantify nerve conduction study
(NCS) reproducibility utilizing an automated NCS system
(NC-stat
, NeuroMetrix, Inc.). Method. Healthy volunteers
without neuropathic symptoms participated in the study. Their
median, ulnar, peroneal, and tibial nerves were tested twice
(7 days apart) by the same technician with an NC-stat

instrument. Pre-fabricated electrode arrays speciﬁc to each
nerve were used. Both motor responses (compound motor
action potential [CMAP] and F-waves – all nerves) and sensory
responses (sensory nerve action potentials [SNAP] – median and
ulnar nerves only) were recorded following supramaximal
stimuli. Automated algorithms determined all NCS
parameters: distal motor latency (DML), mean F-wave latency
(FWL), distal sensory latency (DSL), CMAP amplitude, and
SNAP amplitude. Latency was adjusted for skin temperature
deviation from reference. Pearson correlation coefﬁcient (CC),
intraclass correlation coefﬁcient (ICC), coefﬁcient of variance
(CoV), and relative intertrial variation (RIV) were
calculated. Results. Fifteen subjects participated in either
upper or lower extremity studies with nine participating in
both. With the exception of CMAP amplitude, all parameters
had CoV less than 0.06. Upper extremity amplitude parameters
had CCs greater than 0.85. CCs for latencies were greater than
0.80 except for the median nerve FWL (CC = 0.69). For lower
extremity nerves, ICCs were highest for mean FWL (>0.90),
followed by DML (>0.82) and then CMAP (peroneal 0.33,
tibial 0.73). The 10th to 90th RIV percentiles were bounded by
±7% for F-wave latencies;±9% for all DSLs; and±11% for
DML (except peroneal at 15%). Conclusions. The
reproducibility of NCS parameters obtained with an
automated NCS instrument compared favorably with
traditional electromyography laboratories. F-wave latencies
had the highest repeatability, followed by DML, DSL, SNAP
and CMAP amplitude. Given their high reproducibility,
automated NCS instrument may encourage wider utilization
of NCS in clinical and research applications.
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INTRODUCTION
Nerve conduction studies (NCS) are an objective, quan-
titative, and reproducible measure of peripheral nerve
function and are widely used in the diagnosis of neur-
opathies [1, 2]. They can be used to monitor neuropathic
disease progression [3] and the efﬁcacy of interventions in
clinical trials [4]. However, non-uniform electrophysio-
logic test procedures degrade reproducibility. Potential
sources of variation include the use of different EMG
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tent placement of recording and stimulating electrodes [6],
use of non-standardized distance measurements, use of
sub-maximal electrical stimuli, poor skin preparation
resulting in high skin impedance, and failure to maintain
limb temperature within an acceptable range or to com-
pensate for temperature. All these factors may compro-
mise the repeatability of NCS measurement and lead to
erroneous diagnostic conclusions.
Aside from true physiological changes, factors that
inﬂuence repeatability of NCS measurements are broadly
grouped into two categories: inter-tester variability and
intra-tester variability. Inter-tester variability refers to var-
iability of a test parameter measured on a single individual
when repeat test measurements are made by two or more
examiners. Intra-tester variability refers to variability of a
testparameterwhenrepeattestmeasurementsaremadebya
single examiner. In the absence of physiological changes,
both inter-tester and intra-tester variability are inﬂuenced
by electrodiagnostic examination technique. Automated
NCS instruments may improve NCS repeatability by uti-
lizingprefabricatedelectrodearraysandautomatingevoked
waveform analysis [7]. The objective of this study is to
quantify NCS repeatability utilizing the NC-stat
 (Neu-
roMetrix, Inc., Waltham, Massachusetts), an automated
NCS system [8–10]. We hypothesized that use of the NC-
stat system would yield highly reproducible NCS results.
METHODS AND MATERIALS
Subjects
Subjects volunteered for the study and provided written,
informed consent. All were healthy ofﬁce workers who
lacked neurological complaints or known causes of
peripheral neuropathy. The study was approved and
monitored by an independent review board (Copernicus
Group, Cary, NC, USA).
Nerve conduction studies
Each upper and lower extremity nerve was tested twice
(7 days apart) by the same technician, utilizing the NC-
stat
 (NeuroMetrix, Inc., Waltham, MA, USA), an
automated NCS instrument. Shown in Figure 1 is a
photograph of the NC-stat system components: pre-fab-
ricated electrode arrays speciﬁc to peroneal nerve motor
testing; an electronic monitor to be connected to the
electrode arrays for nerve stimulation and waveform
acquisition and analysis; a communication port to transmit
data for report generation. The NC-stat system is FDA
510(k) cleared for the performance of motor studies of the
median, ulnar, peroneal and tibial nerves, and sensory
studies of the median, ulnar and sural nerves. Tests were
performed in a commercial ofﬁce setting similar to a
physicians ofﬁce where NC-stat systems are typically
used. Upper extremity and lower extremity repeatability
studies were carried out separately. Each study lasted for
about 2 weeks to complete the 7-day interval test-retest
protocol for 15 subjects. A technician applied pre-fabri-
cated electrode arrays speciﬁc to each nerve based on
readily identiﬁable anatomic landmarks. The electrode
arrays incorporated stimulating, recording, and ground
electrodes, as well as a temperature sensor. The device
automatically checked skin impedance and determined
the minimum stimulator current needed to deliver a su-
pramaximal stimulus with amplitude ranging from 10 to
100 mA and duration between 100 and 500 ls. The
evoked compound muscle (CMAP) or compound sensory
nerve (SNAP) action potentials were recorded following a
series of supramaximal stimuli. Supramaximal is deﬁned as
CMAP amplitudes having less than 10% variation from
their mean for three stimuli of increasing intensities (step
size varies between 2.5 and 20 mA depending on nerve
and stimulus duration). SNAPs are acquired at the motor
supramaximal stimulation level since NC-stat recorded
both motor and sensory responses simultaneously to
minimize overall stimulus count [10]. Time interval be-
tween stimuli is about 2–3 s. The technician was trained
according to the manufacturers instructions and was
blinded to the prior test results during the retest.
The median stimulator cathode was placed over the
midline volar wrist 3 cm proximal to the distal wrist crease.
A volume-conducted median motor response generated
by abductor pollicis brevis was recorded using paired
electrodes placed over the lateral and medial aspects of the
distal wrist crease [8]. Concurrently, an antidromic SNAP
was recorded from the middle ﬁnger using self-adhering
ring electrodes placed around the proximal interphalangeal
(PIP) joint (active electrode), with the inactive electrode
3 cm distal. The ulnar stimulating cathode was placed over
the medial volar wrist 3 cm proximal to the distal wrist
crease. The ulnar motor response was recorded using an
active electrode placed over abuductor digiti minimi and
an inactive electrode placed over the lateral volar wrist.
The ulnar SNAP was recorded from the small ﬁnger with
the active electrode over the PIP and inactive electrode
2 cm distal. The stimulator cathode for peroneal testing
was placed lateral to the tibia at the intermalleolar line.
Responses were recorded using detector pairs placed along
a line between the lateral malleolus and the 3rd toe, over
the vicinity of the Extensor Digitorum Brevis muscle (see
Figure 1). For tibial nerve testing, stimulating cathode was
placed over the posterior tibial nerve just posterior to the
406 Journal of Clinical Monitoring and Computingmedial malleolus. Both the active and inactive electrodes
were located just distal to the medial malleolus. The active
electrode was anterior and the inactive electrode was
posterior. A ground electrodeand temperaturesensor were
interposed between stimulating and recording electrodes
in all cases. At the conclusion of NCS for a given subject,
test data were uploaded to a central database.
Sample waveforms are shown in Figure 2. Motor re-
sponses (CMAP and F-wave) were recorded with ﬁlter
settings of 15 Hz high pass and 3 kHz low pass; sensory
responses were recorded with 175 Hz high pass and
3 kHz low pass ﬁlters. Supramaximal CMAP and SNAP
were sampled at 10 kHz and F-waves were acquired at
2.5 kHz. Four CMAP waveforms were acquired for each
nerve. For recording SNAPs, 6–15 individual waveforms
were averaged depending upon the signal-to-noise ratio.
Up to 10 F-wave responses (with 12 traces as a maximum)
were recorded for the median and ulnar nerves. Up to 20
peroneal and tibial F-wave responses (with 40 traces as a
maximum for personal, and 24 traces as a maximum for
tibial) were acquired for lower extremity tests.
NCS Parameters
All NCS parameters were determined by automated
computer algorithms [7, 9, 10]. For motor studies, distal
motor latency (DML) was the time difference between
stimulus onset and initial negative deﬂection (marked as
‘‘+’’ in the lower left panel of Figure 2). DML values
from four CMAP waveforms were averaged and reported
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Fig. 2. Sample motor and sensory responses acquired by the NC-stat nerve conduction instrument during the repeatability study for one subject. Top left
panel shows the ulnar sensory nerve action potential (SNAP) with distal sensory latency (DSL) marked by an open circle. Bottom left panel shows the ulnar
compound muscle action potential (CMAP) with distal motor latency (DML) marked with a plus and negative peak marked with a triangle for peak-to-base
amplitude calculation. Right panel shows the tibial F-wave traces. Pluses indicate the NC-stat assigned F-wave latencies for individual traces with F-wave
response. Dotted line is the calculated mean F-wave latency for the F-wave set.
Fig. 1. Photograph of the NC-stat instrument. It consists of three com-
ponents: pre-fabricated electrode arrays (biosensor, left panel) for a peroneal
motor nerve conduction study, an electronic monitor (connected to a biosensor
during testing), a report generation system (not shown) based on electro-
physiological data collected and processed by the monitor and transmitted via
‘‘docking station’’ (a telecommunication port for secure data transfer via
telephone line).
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measured baseline to negative peak (upward deﬂection,
identiﬁed by the upper triangle) based on the averaged
CMAP. F-wave onset latency was identiﬁed for each trace
with an identiﬁed F-wave response (traces with ‘‘+’’, right
panel of Figure 2), and their average was reported as the
mean F-wave latency (vertical dotted line) [9]. The distal
sensory latency (DSL) was measured from stimulus onset
to the initial negative peak (upward deﬂection) of the
SNAP (open circle in the upper left panel of Figure 2).
The SNAP amplitude was measured peak to peak (neg-
ative-positive, or vertical distance between open and
closed circles) [10]. Both sensory parameters were based
on the averaged waveform. All motor and sensory laten-
cies were adjusted for deviation of skin surface tempera-
ture from reference values (32 C upper extremity, 30 C
lower extremity) with a linear correction formula:
Latency(corrected) = Latency (raw))CorrCoef*(Tem-
perature)Reference). The temperature correction factor
CorrCoef was previously determined in an independent
study population (150 subjects, data on ﬁle), which also
found dependence of CMAP and SNAP amplitude on
temperature to be not statistically signiﬁcant.
Statistical analysis
Statistical measures used to quantify NCS repeatability
mirrored those used in prior studies [2, 4, 5]. The Pearson
product-moment correlation (CC) was used to assess the
association between NCS parameters obtained 7 days
apart. Intraclass correlation coefﬁcient (ICC) was used to
determine the agreement between the two tests. Coefﬁ-
cient of variation (CoV) of test-retest NCS parameters
was calculated and the average over all nerves was re-
ported. Relative intertrial variation (RIV) was used to
assess data variability. The RIV is the difference between
two tests as a percentage of the average of the two tests
[2]. Because of the small sample size, 10th and 90th per-
centiles of RIV were calculated for all parameters to
minimize the impact of outliers. To facilitate comparison,
the 5th and 95th percentile values, as reported by others
[2], were also obtained for selected parameters. The mean
and standard deviation of the difference between the test
and retest results were also reported. Paired t-tests were
carried out to ensure that two tests yielded NCS param-
eters with the same mean.
RESULTS
A total of 21 healthy volunteers participated in this study.
Fifteen subjects (4 females) participated in the upper
extremity repeatability study. Their ages ranged from 24
to 52 years (mean 37.1, SD 8.6 years). Height varied from
157 to 180 cm (mean 173, SD 7.9 cm). Total of 15
subjects (5 females) volunteered for the lower extremity
repeatability study and nine of them had also enrolled in
the upper extremity study. Their age range was 22–
47 years (mean 32.6, SD 8.2 years) and height range was
157–180 cm (mean 172, SD 8.2 cm). Statistical analysis
results for NCS parameters are tabulated in Table 1. The
RIVs for mean FWL at 5th and 95th percentiles were
[)11.4%, 9.4%], [)5.1%, 3.3%], [)4.9%, 4.5%], and
[)2.8%, 4.0%], respectively, for median, ulnar, peroneal,
and tibial nerves. At P = 0.05 level, paired t-tests indi-
cated that the means of all test and retest NCS parameters
were the same. Pearson CCs for all latency parameters
were greater than 0.80 with the exception of median
nerve mean FWL (CC = 0.69). All upper extremity
amplitude parameters had CCs greater than 0.85. For
lower extremity nerves, repeatability measures were
highest for mean FWL, followed by DML and then
CMAP. All latency results were based on temperature
corrected latencies. Without temperature compensation,
latency parameters exhibited lower repeatability. For
example, the CC values for ulnar nerve DML, mean
FWL, and DSL without temperature correction were
0.72, 0.93, and 0.72, respectively. Standard deviation of
the difference between test and retest results would have
been 0.31, 1.04, and 0.34. No temperature correction was
performed for amplitude parameters reported in Table 1.
DISCUSSION
Several studies (summarized in Table 2) have examined
NCS parameter repeatability [2, 4, 5]. In [4], the repeat-
ability of NCS was evaluated for 60 sites participating in a
clinical trial, with NCS oversight performed by ‘‘an
experienced, insightful and knowledgeable core lab’’. Our
study yielded similar results, though our study demon-
strated a higher CoV for peroneal CMAP amplitude (9%
vs. 29.8%). In [2], 132 healthy subjects were retested at a
time interval of 1–4 weeks and ICC and RIV were used
to measure the test-retest repeatability. In comparison
with that study, our study had higher ICC values for all
NCS parameters except for tibial CMAP. The RIV (5th
and 95th percentile) for tibial nerve F-wave latency was
tighter in our study ([)2.8%, 4.0%] vs. [)4.6%, 5.7%])
while the relationship was reversed for median nerve F-
wave latency results ([)11.4%, 9.4%] vs. [)6.7%, 6.7%]).
Decreased repeatability of median nerve F-wave latency
may be attributed to the lower amplitude signal-to-noise
ratio as median nerve F-waves were acquired via a
408 Journal of Clinical Monitoring and Computingvolume-conduction recording technique. Indeed, latency
repeatability was much higher for ulnar F-waves recorded
directly over the muscle. The ICC for ulnar F-wave la-
tency was 0.92 in our study, higher than the ICC of 0.59
reported in a similar study of 49 healthy adults [11]. Sal-
erno and colleagues studied upper extremity sensory test-
retest repeatability based on 158 active workers who were
tested by a neurologist and a physiatrist [5]. Our results fell
into the upper range of their repeatability results as
measured by CC and ICC.
Our study had lower CMAP amplitude repeatability
than some other studies. The cause of this is uncertain. It
is possible that the small recording electrodes (surface
areas 2c m
2) used in our study degraded repeatability,
since Tjon-A-Tsien and colleagues noted that when
electrode size was changed from 0.78 to 7.65 cm
2, the
CoV of CMAP amplitude improved from 11 to 7%
(lower CoV is associated with higher repeatability) [12].
DML repeatability was less affected by electrode size in
both our study and the study of [12].
Skin temperature changes have a predictable effect on
motor and sensory latencies [13]. However, control of
skin temperature is often difﬁcult to achieve, especially in
different testing environments. In the present study, skin
temperature adjacent to the recording site was acquired
automatically using an embedded probe and latencies
were adjusted to the reference temperature. As expected,
temperature correction improved NCS repeatability. For
example, the CC increased from 0.72 (without temper-
ature correction) to 0.89 (with correction) for both motor
and sensory latencies of the ulnar nerves. Temperature
correction also reduced the standard deviation of the test-
retest latency difference by as much as 39% (ulnar DML).
The principal limitation of the current study was the
small number of subjects evaluated relative to several prior
investigations. The short test-retest interval of 1 week
Table 1. Statistical measures of nerve conduction study parameter repeatability
RIV Percentiles (Day 8–Day 1)
Nerve CC ICC CoV 10th (%) 90th (%) Mean Stdev Paired t-test
Distal motor latency (DML)
Median 0.872 0.870 0.032 )9.5 5.1 )0.055 0.194 0.289
Ulnar 0.889 0.832 0.045 )8.3 11.0 0.026 0.190 0.605
Peroneal 0.864 0.845 0.061 )15.4 8.1 )0.124 0.453 0.307
Tibial 0.850 0.824 0.038 )6.8 8.8 0.016 0.239 0.799
Mean F-wave latency (FWL)
Median 0.692 0.679 0.031 )6.6 4.4 )0.037 1.970 0.943
Ulnar 0.949 0.921 0.017 )3.9 1.1 )0.286 0.915 0.246
Peroneal 0.896 0.901 0.017 )4.7 3.4 )0.163 1.563 0.693
Tibial 0.943 0.940 0.013 )1.8 3.5 0.278 1.145 0.363
Distal sensory latency (DSL)
Median 0.887 0.879 0.028 )7.2 4.0 )0.056 0.189 0.270
Ulnar 0.815 0.797 0.037 )5.7 9.0 0.012 0.207 0.825
Compound muscle action potential (CMAP) amplitude
Median 0.879 0.862 0.109 )19.2 19.9 0.031 0.198 0.550
Ulnar 0.981 0.974 0.045 )5.7 10.7 0.288 0.609 0.088
Peroneal 0.392 0.331 0.298 )30.8 99.5 0.849 1.937 0.112
Tibial 0.714 0.728 0.148 )30.9 25.4 )0.165 1.601 0.695
Sensory nerve action potential (SNAP) amplitude
Median 0.954 0.954 0.058 )11.8 7.8 0.673 8.402 0.761
Ulnar 0.990 0.982 0.042 )4.4 10.9 1.485 5.063 0.275
CC: Pearson product moment correlation to assess the association between test-retest results. ICC: Intraclass correlation coefﬁcient to
determine the agreement between test-retest results. CoV: Coefﬁcient of variation normalizes the standard deviation by its corresponding
mean. RIV: Relative interval variation deﬁnes the difference between test-retest as a percentage of average. Paired t-test results indicate the
means of test and retest are not statistically different. DSL is the negative peak latency and SNAP amplitude is the peak-to-peak amplitude
difference. DML is the onset of initial deﬂection and CMAP is negative peak to baseline amplitude difference. FWL is the arithmetic mean of
individual F-wave latencies in an F-wave set.
Kong et al.: NCS Repeatability using Automation 409reduced the likelihood of intervening physiological
changes. Prior studies have shown worse repeatability for
pathologic nerves. It would be valuable to quantify
repeatability of the automated NCS instrument in neu-
ropathic nerves. At the time of this study, the amplitude
parameters were not compensated for temperature varia-
tion by NC-stat system. Temperature correction may
improve the repeatability of the amplitude parameters,
especially for sensory responses.
Repeatability was quantiﬁed for NCS parameters ob-
tained with an automated NCS instrument. The results
compared favorably with those obtained at academic and
community electromyography laboratories. The repro-
ducibility of individual NCS parameters followed the
same pattern as those observed in traditional settings. F-
wave latency had the greatest repeatability, followed by
DML, DSL, and SNAP amplitude. The CMAP amplitude
was the least reproducible parameter, with peroneal
CMAP amplitude repeatability the lowest among all
nerves. A larger recording electrode size should improve
its repeatability. F-wave latency repeatability for median
nerve was lower due to the lower signal-to-noise ratio
inherent in volume-conduction recordings. As a result,
over-muscle recording would be expected to enhance F-
wave repeatability, which was the case for the ulnar nerve.
Further studies with longer test-retest intervals and a
higher subject count would be valuable in conﬁrming the
high reproducibility of NCS parameters measured in this
study. Extending the study to pathologic nerves and val-
idating the equivalent or superior performance of auto-
mated NCS instrument should increase the adoption rate
of the automated NCS technology in patient manage-
ment.
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Table 2. Repeatability results reported in the literatures
Nerve CC ICC CoV
Distal motor latency (DML)
Median 0.826
a 0.04
b/0.08
c
Peroneal 0.05
b/0.08
c
Tibial 0.617
a 0.08
c
Minimum F-wave latency (FWL)
Ulnar 0.59
d
Tibial 0.921
a
Distal sensory latency (DSL)
Median 0.82–0.92
e 0.82–0.92
e 0.04
b
Ulnar 0.37–0.64
e 0.32–0.63
e
Compound muscle action potential (CMAP) amplitude
Median 0.777
a 0.07
b/0.11
c
Peroneal 0.09
b
Tibial 0.846
a
Sensory nerve action potential (SNAP) amplitude
Median 0.83–0.88
e 0.834
a/0.81–0.88
e 0.08
b
Ulnar 0.68–0.85
e 0.68–0.85
e
a 132 healthy subjects retested in 1–4 weeks [2].
b Results for
control subjects from 60 sites with core lab support in a clinical trial
[4].
c 33 subjects retested in 1–2 week, results for small electrode
size (0.78 cm
2) and all three nerves combined [12].
d 57 healthy
volunteers retested 3 days apart [11].
e158 active workers examined
by a neurologist and physiatrist on the same day [5].
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